Results 111 to 120 of about 6,916 (124)

Annotated checklist of the amphibians and reptiles of Zacatecas, Mexico. [PDF]

open access: yesZookeys
Sigala-Rodríguez JJ   +7 more
europepmc   +1 more source

Correction: Hypertension as predictive factor for bevacizumab-containing first-line therapy in metastatic breast and colorectal cancer in BRECOL (GEICAM/2011-04) study. [PDF]

open access: yesClin Transl Oncol
Rodríguez-Lescure Á   +23 more
europepmc   +1 more source

Genetic Testing After Heart Transplantation Uncovers Heritable Disease and Drives Family Screening. [PDF]

open access: yesJACC Adv
Moliner-Abós C   +33 more
europepmc   +1 more source

Second Report of the American Intestinal Transplant Working Group: New Insights Into Risk Factors, Treatment Regimens, and Outcomes of Malignancy After Intestinal Transplantation. [PDF]

open access: yesTransplantation
Chiu CEN   +27 more
europepmc   +1 more source

Comparison of Anthropometric Equations to Estimate Body Composition in Chilean Male Adolescent Soccer Players. [PDF]

open access: yesJ Funct Morphol Kinesiol
Farfán-Díaz Á   +8 more
europepmc   +1 more source

Measles outbreak in an occupational setting: challenges to regain elimination status for Spain, 14 January to 11 April 2026. [PDF]

open access: yesEuro Surveill
Aznar E   +18 more
europepmc   +1 more source

First-line osimertinib in advanced <i>EGFR</i>-mutated NSCLC: real-world outcomes, clinicogenomic correlates, and oligoprogression management in a multicenter Spanish cohort. [PDF]

open access: yesESMO Real World Data Digit Oncol
Suay G   +17 more
europepmc   +1 more source

Predictors of emotional well-being in university professors using Machine Learning. [PDF]

open access: yesF1000Res
Bravo-Alvarado RN   +8 more
europepmc   +1 more source

Real-World Outcomes across Baseline Risk Profiles in Patients with COPD Initiating Budesonide/Glycopyrronium/Formoterol Fumarate Dihydrate in Spain: Insights from the ORESTES Study. [PDF]

open access: yesPulm Ther
Alcázar-Navarrete B   +15 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy